Vericel Corp (VCEL)
46.11
-0.31
(-0.67%)
USD |
NASDAQ |
Apr 24, 16:00
46.09
-0.02
(-0.04%)
After-Hours: 20:00
Vericel Cash from Operations (TTM): 35.31M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.31M |
| September 30, 2023 | 32.20M |
| June 30, 2023 | 29.13M |
| March 31, 2023 | 22.08M |
| December 31, 2022 | 17.69M |
| September 30, 2022 | 21.26M |
| June 30, 2022 | 20.80M |
| March 31, 2022 | 22.42M |
| December 31, 2021 | 29.04M |
| September 30, 2021 | 29.83M |
| June 30, 2021 | 30.76M |
| March 31, 2021 | 22.97M |
| December 31, 2020 | 17.57M |
| September 30, 2020 | 9.385M |
| June 30, 2020 | 12.71M |
| March 31, 2020 | -2.651M |
| December 31, 2019 | -7.183M |
| September 30, 2019 | -7.722M |
| June 30, 2019 | -13.60M |
| March 31, 2019 | -0.663M |
| December 31, 2018 | -0.412M |
| September 30, 2018 | -2.189M |
| June 30, 2018 | -9.443M |
| March 31, 2018 | -9.656M |
| December 31, 2017 | -13.18M |
| Date | Value |
|---|---|
| September 30, 2017 | -23.32M |
| June 30, 2017 | -22.27M |
| March 31, 2017 | -21.74M |
| December 31, 2016 | -19.89M |
| September 30, 2016 | -14.62M |
| June 30, 2016 | -11.16M |
| March 31, 2016 | -10.50M |
| December 31, 2015 | -13.35M |
| September 30, 2015 | -15.55M |
| June 30, 2015 | -23.26M |
| March 31, 2015 | -24.85M |
| December 31, 2014 | -25.41M |
| September 30, 2014 | -23.51M |
| June 30, 2014 | -19.22M |
| March 31, 2014 | -17.86M |
| December 31, 2013 | -19.94M |
| September 30, 2013 | -22.94M |
| June 30, 2013 | -26.45M |
| March 31, 2013 | -29.70M |
| December 31, 2012 | -29.54M |
| September 30, 2012 | -28.35M |
| June 30, 2012 | -26.84M |
| March 31, 2012 | -24.68M |
| December 31, 2011 | -24.49M |
| September 30, 2011 | -22.88M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-13.60M
Minimum
Jun 2019
35.31M
Maximum
Dec 2023
16.95M
Average
21.26M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Arbutus Biopharma Corp | -85.94M |
| Chimerix Inc | -69.09M |
| Karyopharm Therapeutics Inc | -92.72M |
| Axsome Therapeutics Inc | -145.08M |
| Y-mAbs Therapeutics Inc | -27.23M |